Study of cancer treatment and outcomes during pregnancy
Part of Cancer clinical trials.
This study looks at pregnant people who were diagnosed with cancer around pregnancy and how care affects the mother, baby, and newborn. It aims to better understand outcomes and treatment patterns during pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently pregnant, or recently pregnant, and were diagnosed with cancer
- Your cancer diagnosis was within 6 weeks before your last menstrual period, OR within 6 months after delivery or miscarriage
- Your diagnosis must be around the time of pregnancy (delivery or miscarriage counts)
- If your cancer diagnosis happened more than 6 months after the end of a pregnancy, you are not eligible
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how cancer and its treatment during pregnancy affect a pregnant person and their child. It may help doctors better plan care and follow-up for future pregnancies and growing children.
This study follows pregnant people who had unusual noninvasive prenatal blood test results, to better understand the natural course and possible causes, including concerns about maternal cancer. You may join during pregnancy or up to 2 years after delivery, and you would share medical information and undergo follow-up visits.
This study is for adults with breast cancer who are pregnant and are either newly diagnosed (early) or have locally advanced or metastatic disease. It aims to better understand how breast cancer treatment should be managed during pregnancy.
This study looks at how the immune system changes in people with breast cancer, using patient tissue samples. It may help researchers understand immune responses in young women and guide future cancer treatments.
This study looks at whether having been pregnant in the past influences how well immunotherapy (PD-1/PD-L1 inhibitors) works for endometrial or cervical cancer. The goal is to see if pregnancy history might be linked to better or worse outcomes.
This study looks at fetal DNA in the blood of pregnant women who have cancer, to better understand how the baby and tumor interact. It might help doctors learn more about how cancer affects pregnancy.
Hear when a new Pregnancy, Cancer, Cancer in Pregnancy, Gestational Breast Cancer, Pregnancy Related trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.